Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,643,135
  • Shares Outstanding, K 54,951
  • Annual Sales, $ 54,580 K
  • Annual Income, $ -555,630 K
  • 60-Month Beta 2.62
  • Price/Sales 136.44
  • Price/Cash Flow N/A
  • Price/Book 3.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -2.80
  • Number of Estimates 12
  • High Estimate -2.31
  • Low Estimate -3.29
  • Prior Year -2.31
  • Growth Rate Est. (year over year) -21.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.13 +2.25%
on 04/18/19
163.43 -16.71%
on 04/03/19
-10.52 (-7.17%)
since 03/22/19
3-Month
121.01 +12.49%
on 01/29/19
163.43 -16.71%
on 04/03/19
+13.33 (+10.86%)
since 01/24/19
52-Week
87.49 +55.58%
on 12/24/18
199.70 -31.84%
on 06/04/18
-26.88 (-16.49%)
since 04/24/18

Most Recent Stories

More News
Anthem's (ANTM) Q1 Earnings Beat Estimates, Improve Y/Y

Anthem's (ANTM) Q1 earnings surge on the back of a solid operating performance and strong growth across all core businesses.

HUM : 249.89 (+0.58%)
BLUE : 136.12 (-2.14%)
ANTM : 251.00 (+0.14%)
ADRO : 3.57 (+1.13%)
Bluebird Bio Inc Set to Possibly Rebound After Yesterday's Selloff of 2.05%

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $133.60 to a high of $137.65. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of...

BLUE : 136.12 (-2.14%)
Bluebird Bio Inc Falls 2.17% on Heavy Volume: Watch For Potential Rebound

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $151.37 to a high of $156.19. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

BLUE : 136.12 (-2.14%)
Look for Shares of Bluebird Bio Inc to Potentially Rebound after Yesterday's 2.74% Sell Off

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $152.33 to a high of $158.32. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of...

BLUE : 136.12 (-2.14%)
Potential Blockbuster Gene Therapy Programs to Watch in 2019

Several revolutionary gene therapies appear to be on the verge of delivering remarkable remedies for diseases that have previously been viewed as untreatable.

SGMO : 11.88 (-1.00%)
QURE : 54.70 (-0.65%)
BLUE : 136.12 (-2.14%)
LPTX : 1.73 (+0.58%)
GNPX : 1.78 (-0.63%)
Celgene & Acceleron Submit BLA for Luspatercept to the FDA

Celgene (CELG) and partner Acceleron submit BLA for pipeline candidate, luspatercept to the FDA.

CELG : 93.10 (-0.61%)
BLUE : 136.12 (-2.14%)
XLRN : 40.54 (-2.43%)
BMY : 44.62 (-1.54%)
Uptrend Call Working As Bluebird Bio Inc Stock Rises 44.5% (BLUE)

SmarTrend identified an Uptrend for Bluebird Bio Inc (NASDAQ:BLUE) on January 7th, 2019 at $110.74. In approximately 3 months, Bluebird Bio Inc has returned 44.49% as of today's recent price of $160.00....

BLUE : 136.12 (-2.14%)
Look for Shares of Bluebird Bio Inc to Potentially Pullback after Yesterday's 1.96% Rise

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $154.57 to a high of $157.54. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high...

BLUE : 136.12 (-2.14%)
Global Blood Focuses on Developing Lead Candidate Voxelotor

Global Blood (GBT) is fast progressing on the development plans for its lead pipeline candidate, voxelotor for the treatment of sickle cell disease.

BLUE : 136.12 (-2.14%)
GBT : 55.42 (-1.77%)
NVS : 77.82 (+2.53%)
PFE : 39.37 (-0.13%)
bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO(TM) (autologous CD34+ cells encoding BA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent B-Thalassemia (TDT) Who Do Not Have B0/B0 Genotype

--Treatment with ZYNTEGLO has been shown to help eliminate the need for chronic blood transfusions in patients with TDT

BLUE : 136.12 (-2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BLUE with:

Business Summary

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio,...

See More

Key Turning Points

2nd Resistance Point 142.32
1st Resistance Point 139.22
Last Price 136.12
1st Support Level 133.81
2nd Support Level 131.50

See More

52-Week High 199.70
Fibonacci 61.8% 156.84
Fibonacci 50% 143.60
Last Price 136.12
Fibonacci 38.2% 130.35
52-Week Low 87.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar